These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23939897)

  • 1. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
    Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
    Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
    Leang R; Barrette A; Bouth DM; Menard D; Abdur R; Duong S; Ringwald P
    Antimicrob Agents Chemother; 2013 Feb; 57(2):818-26. PubMed ID: 23208711
    [TBL] [Abstract]